Allvivo Vascular, Inc.
Publicly observedLake Forest, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Lake Forest | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Allvivo Vascular, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | R2LPKTLGG785 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant7 Mar 2018Publicly observed
NIH SBIR/STTR award: Antimicrobial Treatment to Combat Wound Biofilm
USD 999,999.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant7 Mar 2018Publicly observed
NIH SBIR/STTR award: Antimicrobial Treatment to Combat Wound Biofilm
USD 999,985.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.